What is APACMed?
APACMed is the main representative for all key stakeholders surrounding the medical technology industry in Asia-Pacific. Its prime objective is to promote the importance of innovation and the value of transparency in every collaborative interaction.
The Code concerns you especially if:you are a physician / nurse / allied professional wishing to join AsiaPCRyou are a physician / nurse / allied professional wishing to join PCR Tokyo Valvesan industry partner willing to support delegate / faculty attendance. Get in touch with us!
Questions & answers for participants
Exchanges between industry members, Healthcare Professionals and Healthcare Organisations are evolving under new Medtech Europe regulations which have come into force on 01 January 2018. What exactly does this mean for Healthcare Professionals? How do I get on board with these changes? Your most frequently asked questions are answered in this section.
Questions & answers for Industry Partners
For further information on the MedTech Europe Code of Ethics please visit our FAQ page dedicated to our IndustrExchanges between industry, Healthcare Professionals and Healthcare Organisations (including Professional Congress Organisers - PCO) are evolving under new regulations which have come into force on 1st January 2018. What exactly does this mean for Industry Partners? How can they get on board with these changes? Your most frequently asked questions are answered in this section. Partners.
First in human implantation of a novel transfemoral self-expanding transcatheter heart valve to treat pure aortic regurgitation
The first case of a novel JenaValve design using the transfemoral approach in a 78 year old female patient with pure aortic regurgitation is described in this article.
Aortic stenosis prevalence and balloon aortic valvuloplasty publish
The transformation in the field of interventional cardiology is unprecedented. Since the late 1970's, rapid changes have taken place, and today, interventional cardiology encompasses an ever-growing list of diagnostic and therapeutic percutaneous procedures performed in the cathlab. The field was initially driven by the treatment of the vasculature system, but has expanded over the last 15 years to structural heart disease.
First FIM Percutaneously Implanted Heart Valve (PHV) implantation on 16 April, 2002
On April 16, 2002, at the Charles Nicolle University Hospital in Rouen, France, the Interventional Cardiologist, Professor Alain Cribier performed the first transcatheter aortic valve replacement procedure in the world. He used a Prosthetic valve thrombosis (PVT) percutaneous heart valve.
Alain G. Cribier
Alain Cribier, M.D., FACC, FESC (born in 1945) is a French interventional cardiologist and is a Professor of Medicine and Director of Cardiology at the University of Rouen's Charles Nicolle Hospital, France.As part of celebrating the 15th year of TAVI, we are presenting a summary of Alain Cribier’s career highlights and quests.This page is dedicated to the personal life and accomplishments.
Indirect Educational Sponsorship
The new MedTech Europe Code of Ethics has come into force since 1st January 2018. Set to regulate interactions between industries, Healthcare Professionals and Healthcare Organisations (ex: learned societies, conference organisers, associations, et al.), this Code prevents improper perceptions regarding funding support and/or various actions taken by industries in the context of third-party organised events. Concretely:The Code aims at reinforcing the independence of said events by offering an indirect sponsorship scheme to support the participation of Healthcare ProfessionalsEuropa Group/PCR — MedTech Europe trusted third party — is equipped to receive Educational Allowances from Industry PartnersPractitioners shall contact their institutions in regards of educational allowances In order to become eligible for the attribution of educational allowances, it is highly advised for practitioners to:keep their MyPCR account up-to-dateTake part in the PCR Call for Submissions
MedTech Europe and its regional counterparts are proactive in advocating industries self-regulation and creating a safe environment that helps strengthen the independence of Healthcare Professionals’ decision-making.
The new regulation has come into force on 1 January 2018.
What is MedTech Europe?
A broad modification of the MedTech Europe "Code of Ethical Business Practice" is underway. This change is devised to bring further transparency to the making and handling of third-party organised educational events.
The Code concerns you especially if:you are a physician / nurse / allied professional wishing to join EuroPCR 2018 and/or PCR London Valves 2018an industry partner willing to support delegate / faculty attendance. Get in touch with us!
New regulations, an opportunity for Industry Partners
As a trusted third-party, Europa Group is fully committed to perpetuating long-term collaboration between industry partners and healthcare professionals. We are deeply involved in the matter of Educational Events for cardiovascular specialists and are willing to ensure that, as of 1st January 2018, industry partners can continue to take an active part in supporting practitioners’ attendance to our Courses.